RSS

 

Genoscience Pharma will present on October 22nd, 2017, from 12:30PM to 02:00 PM,

GNS561 as a new quinoline derivative that inhibits the growth of hepatocellular carcinoma in a cirrhotic rat and human PDX orthotopic mouse models